TCT 254: Importance of Change in LVEF with PCI on Risk of Cardiac Death or Hospitalization for Heart Failure in Pateients With Stable Ischemic Cardiomyopathy
Presenter:
We Recommend
Disclosures
Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:
- Consultant Fee/Honoraria/Speaker’s Bureau - Abbott Vascular; Biotronik; Medtronic
- Equity/Stock(s)/Options - Heartbeam
- Grant Support/Research Contract - Siemens Healthineers